This screening identified a potential candidate, artesunate, an FDA-approved drug widely used to treat choice globally in adults hospitalized with severe malaria.37 Molecular docking data of DDX39B-artesunate revealed that artesunate occupies the groove region where DDX39B interacts with TRIM28 (Fig. 8a). This evidence concerns the gene TRIM28 and malaria.